Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026)
Vertex Pharmaceuticals' (VRTX) quarterly Tax Rate came in at 17.68% in Q1 2026, up 616.0% year-on-year from 2.47% in Q1 2025, and up 68.2% quarter-over-quarter from 10.51% in Q4 2025.
Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Tax Rate history runs 16 years deep, the most recent figure standing at 17.68% for Q1 2026.
- On a quarterly basis, Tax Rate rose 616.0% year-over-year to 17.68% in Q1 2026; TTM through Mar 2026 was 16.02%, a 24543.0% increase from a year earlier, with the FY2025 full-year figure at 14.86%, down 30067.0% from the prior year.
- Tax Rate improved to 17.68% in Q1 2026 per VRTX's latest filing, from 10.51% in the prior quarter.
- Across five years, Tax Rate topped out at 23.95% in Q4 2022 and bottomed at 5.97% in Q2 2024.
- The 5-year median for Tax Rate is 17.68% (2026), against an average of 16.15%.
- Across the five-year window, Tax Rate sank 23070 bps in 2022 and jumped 2546 bps in 2025, its largest moves.
- Year by year, Tax Rate stood at 23.95% in 2022, then slumped by 35 bps to 15.58% in 2023, then advanced by 26 bps to 19.67% in 2024, then tumbled by 47 bps to 10.51% in 2025, then jumped by 68 bps to 17.68% in 2026.
- Per Business Quant, the three latest VRTX Tax Rate figures stand at 17.68% (Q1 2026), 10.51% (Q4 2025), and 16.62% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.34 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 5.61 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.29 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.68 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.51 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -13.70 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 7.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.68 |
| Mar 31, 2026 | 17.68 |
| Mar 31, 2026 | 17.68 |
| Dec 31, 2025 | 10.51 |
| Dec 31, 2025 | 10.51 |
| Dec 31, 2025 | 10.51 |
| Sep 30, 2025 | 16.62 |
| Sep 30, 2025 | 16.62 |
| Sep 30, 2025 | 16.62 |
| Jun 30, 2025 | 19.49 |
| Jun 30, 2025 | 19.49 |
| Jun 30, 2025 | 19.49 |
| Mar 31, 2025 | 11.51 |
| Mar 31, 2025 | 11.51 |
| Mar 31, 2025 | 11.51 |
| Dec 31, 2024 | 19.67 |
| Dec 31, 2024 | 19.67 |
| Dec 31, 2024 | 19.67 |
| Sep 30, 2024 | 14.60 |
| Sep 30, 2024 | 14.60 |